Steady progress in the treatment of advanced prostate cancer: a year in review

PURPOSE OF REVIEW: This review is designed to highlight recent research efforts to optimize treatment strategies in men with advanced prostate cancer. RECENT FINDINGS: In hopes of improving outcomes in men with advanced prostate cancer, recent trials have focused on intensifying therapy earlier in the disease course both in men with biochemical recurrence and those with oligometastatic disease. Further research efforts have looked to refine the use of radiopharmaceuticals, targeted therapy, and combinations of existing agents. Finally, systemic therapies with novel targets may expand options for men with treatment-refractory metastatic castration-resistant disease. SUMMARY: Ongoing research focuses on maximizing the benefits of existing therapies while exploring treatments with new mechanisms of action.

Authors

Institutions

Publication Details

Journal
Current Opinion in Oncology
Published
2026-04-01
DOI
https://doi.org/10.1097/cco.0000000000001237
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Steady progress in the treatment of advanced prostate cancer: a year in review

Theodore Stewart Gourdin
Current Opinion in Oncology
Prostate Cancer Treatment and Research
article

Steady progress in the treatment of advanced prostate cancer: a year in review

Theodore Stewart Gourdin
article en

Abstract

PURPOSE OF REVIEW: This review is designed to highlight recent research efforts to optimize treatment strategies in men with advanced prostate cancer. RECENT FINDINGS: In hopes of improving outcomes in men with advanced prostate cancer, recent trials have focused on intensifying therapy earlier in the disease course both in men with biochemical recurrence and those with oligometastatic disease. Further research efforts have looked to refine the use of radiopharmaceuticals, targeted therapy, and combinations of existing agents. Finally, systemic therapies with novel targets may expand options for men with treatment-refractory metastatic castration-resistant disease. SUMMARY: Ongoing research focuses on maximizing the benefits of existing therapies while exploring treatments with new mechanisms of action.

Current Opinion in OncologyVol. 38(3)
Medical University of South Carolina (US)
Good health and well-being
Openalex Percentile: Top 28%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.